Large-scale manufacturing process for Strangvac now secured

Tuesday April 2nd, 2019 | General

We are so glad to be part of such an exciting project with the Swedish company INTERVACC, who we are working with on manufacturing of Strangvac® including the large-scale production of the vaccine against equine strangles. The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the […]

3P Biopharmaceuticals enters into a new manufacturing agreement with the Dutch Biotech Company Xenikos

Monday March 11th, 2019 | General

Pamplona, 11th of March, 2019. 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Dutch biotech company Xenikos B. V. (Xenikos) that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®. 3P and Xenikos started their collaboration in 2015 […]

Expansion of analytical capacities by 3P Biopharmaceuticals

Wednesday February 27th, 2019 | General

3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.   The 3P Analytical Development Area is one of the company’s core competences and is crucial to the state-of-the-art technologies as well as services it provides to the clients.   The development of analytical methods is an essential activity in any process development and manufacturing […]

Merry Christmas and Happy New Year 2019!

Tuesday December 18th, 2018 | General

Our entire team wishes you a Merry Christmas and our Warm Wishes for a wonderful Holiday Season. Our very best wishes for a happy new year filled with health, happiness, and spectacular success!

Welcome to our new website

Tuesday December 11th, 2018 | General

We are pleased to announce the launch of our newly revamped website which creates a user-friendly browsing experience. The new structure provides a more interactive experience, allowing our partners to easily find the information they are looking for. In addition to aesthetically re-designing our website, we have also refined our services category structure to provide […]

3P Biopharmaceuticals successfully completes the expansion and improvement of its facilities

Wednesday December 5th, 2018 | General

3P has implemented a new design in its manufacturing plant increasing its capacities and incorporating innovative equipment and state of the art technologies. The investments made in infrastructure and equipment during 2018 exceed 5 million euros. 3P Biopharmaceuticals has successfully completed the project for the expansion and improvement of its facilities in Noáin (Spain) that […]

Permanent award in the form of the Reconcilia Label

Tuesday December 4th, 2018 | General

Permanent award in the form of the Reconcilia Label. We are proud to have received a permanent award in the form of the Reconcilia Label. Last 27th November, the AMEDNA (Navarre Business Women´s Association) recognized those companies that are engaged in the reconciliation of professional, family and personal life. We have obtained the permanent recognition […]

Annual bioProcessUK Conference 2018

Monday November 12th, 2018 | Events, General

Meet us at the Annual bioProcessUK Conference 2018! The BIA is organizing the 15th Annual bioProcessUK Conference that is taking place in Edinburgh on 20-22 November 2018. The conference goes from strength to strength and 2017 saw over 285 delegates from 160 leading organisations attend to hear the latest news/updates and developments within the manufacturing […]

Spanish Biotech Industry: 3P selected as one of the Main Success Stories

Wednesday October 31st, 2018 | General

3P Biopharmaceuticals has been selected as one of the Main Success Stories in the Spanish biotech sector in the last 10 years. ASEBIO presented last week this report where are described a total of 20 success cases of the Biotechnology Sector in Spain in the last 10 years. These success stories have been carefully selected […]

“ambr15 for cell culture process optimization” Webinar 3P Biopharmaceuticals and Sartorius Stedim Biotech

Monday July 16th, 2018 | General

“ambr15 for cell culture process optimization” Webinar 3P Biopharmaceuticals and Sartorius Stedim Biotech Did you miss our webinar about our experience using ambr® 15 with CHO-S cell line for the production of monoclonal antibodies? Watch it now! What will you learn? High-throughput media and feed screening for cell culture process optimization with multi-parallel micro bioreactors […]